Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K-y Liu
Haploidentical Hematopoietic SCT May Be Superior to Conventional Consolidation/Maintenance Chemotherapy as Post-Remission Therapy for High-Risk Adult ALL
Bone Marrow Transplantation
Transplantation
Hematology
Deleterious Effects of KIR Ligand Incompatibility on Clinical Outcomes in Haploidentical Hematopoietic Stem Cell Transplantation Without in Vitro T-Cell Depletion
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
High-Dose Chemotherapy With Autologous PDSCT as Post-Remission Therapy for AML
Bone Marrow Transplantation
Transplantation
Hematology
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission
Clinical Cancer Research
Cancer Research
Oncology
Post-Remission Therapy of Adult Acute Myeloid Leukemia: High Dose Cytosine-Arabinoside Versus Other Consolidation Regimens
Medicinski Pregled
Medicine
A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Good Outcome of Haploidentical Hematopoietic SCT as a Salvage Therapy in Children and Adolescents With Acquired Severe Aplastic Anemia
Bone Marrow Transplantation
Transplantation
Hematology
Risk Seekers May Be Antisocial After All
Clinical and Experimental Medical Sciences
Status of Minimal Residual Disease Determines Outcome of Autologous Hematopoietic SCT in Adult ALL
Bone Marrow Transplantation
Transplantation
Hematology
Consolidation Treatment for High Risk Solid Tumors in Children With Myeloablative Chemotherapy and Autologous Hematopoietic Progenitor Stem Cell Transplantation
Revista Brasileira de Hematologia e Hemoterapia
Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial
Journal of Cancer
Oncology
